Asthma comes in different subtypes, but diagnosing those subtypes — also known as endotypes — has historically been difficult. Newly published research in JAMA presents an alternative: a nasal swab ...
GlobalData on MSN
BioAffinity and Pictor partner on diagnostics for asthma and COPD
Under the agreement, bioAffinity’s sputum analysis will be combined with Pictor’s proteomic platform to analyse inflammation.
A lung function test used to help diagnose asthma works better in the morning, becoming less reliable throughout the day, Cambridge researchers have found. Using real world data from 1,600 patients, ...
Jul 22, 2026--bioAffinity Technologies, Inc. (Nasdaq: BIAF; BIAFW), a biotechnology company advancing early-stage cancer diagnostics and targeted the ...
Asthma is a common disease that affects people of all ages; however, it is underdiagnosed. Researchers have recently identified a genetic biomarker of asthma that can be tested for using a nasal brush ...
Researchers at the University of Pittsburgh have developed a nasal swab test for children and youth that helps clinicians diagnose specific asthma subtypes, or endotypes, using nasal epithelial gene ...
Scientists at Rutgers Health have discovered that a simple blood test could diagnose asthma and determine its severity, a breakthrough that could transform how the disease is identified and monitored.
Asthma is one of the most common respiratory diseases worldwide, affecting more than 235 million patients. It is often more difficult to diagnose in children than in adults. An early diagnosis is ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results